News of the WeekPatents

Antibody Drug Dispute Ends in $255 Million Cash Payout

See allHide authors and affiliations

Science  04 Nov 2005:
Vol. 310, Issue 5749, pp. 761
DOI: 10.1126/science.310.5749.761a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Developers of a new drug for arthritis last week ended a 2-year dispute over royalties, leading to one of the biggest-ever lump-sum payments on record to academic scientists.